62 results on '"Barison A."'
Search Results
2. Effects of pirfenidone on scar size and ventricular remodeling after myocardial infarction: a preclinical study
Catalog
Books, media, physical & digital resources
3. Prognostic role of the progression of late gadolinium enhancement in hypertrophic cardiomyopathy
4. Assessment of repolarization dispersion by using endocardial unipolar electrograms in patients with brugada syndrome and spontaneous coved-type electrocardiographic pattern
5. Prevalence of amyloid transthyretin cardiomyopathy in elderly subjects from the general population: first results from the CATCH study
6. Restrictive cardiomyopathy: definition and diagnosis
7. Prevalence of amyloid transthyretin cardiomyopathy in elderly subjects from the general population: first results from the CATCH study
8. Cardiac involvement in creatine deficiency syndrome
9. Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis
10. Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis
11. Treatment of cardiac transthyretin amyloidosis: an update
12. Comprehensive cardiovascular magnetic resonance for monitoring the response to therapy in pericardial tuberculosis
13. High-sensitivity cardiac troponin T and NT-proBNP for ruling-in and ruling-out of cardiac amyloidosis
14. Comparison between echocardiography and cardiac magnetic resonance for differential diagnosis of left ventricular hypertrophy
15. Deep learning to diagnose cardiac amyloidosis from CMR findings
16. Relationship between location and size of myocardial infarction and their reciprocal influences on post-infarction left ventricular remodelling
17. Comparison between echocardiography and cardiac magnetic resonance for differential diagnosis of left ventricular hypertrophy
18. Diphosphonate single-photon emission computed tomography in cardiac transthyretin amyloidosis
19. High-sensitivity cardiac troponin T and NT-proBNP for ruling-in and ruling-out of cardiac amyloidosis
20. Deep learning to diagnose cardiac amyloidosis from CMR findings
21. P995The extent of late gadolinium enhancement predicts defibrillator shocks in patients with non-ischaemic heart failure
22. P597Clinical and prognostic correlates of volume/time curve at cardiac magnetic resonance in patients with non-ischemic heart failure and left bundle branch block
23. P5285Pressure-volume relationship by cardiovascular magnetic resonance: feasibility and clinical implications
24. P2728Prognostic impact of left atrial function in patients with cardiac amyloidosis: a cardiac magnetic resonance study
25. 401Prognostic role of late gadolinium enhancement in patients with low-intermediate 5 year HCM SCD risk score: a multicenter study
26. 186A novel echo-doppler approach for quantitative estimation of pulmonary artery wedge pressure and pulmonary vascular resistances
27. P5285Pressure-volume relationship by cardiovascular magnetic resonance: feasibility and clinical implications
28. P2728Prognostic impact of left atrial function in patients with cardiac amyloidosis: a cardiac magnetic resonance study
29. P597Clinical and prognostic correlates of volume/time curve at cardiac magnetic resonance in patients with non-ischemic heart failure and left bundle branch block
30. P2729NT-proBNP and high-sensitivity cardiac troponin T to diagnose cardiac amyloidosis
31. P995The extent of late gadolinium enhancement predicts defibrillator shocks in patients with non-ischaemic heart failure
32. Treatment of cardiac transthyretin amyloidosis: an update
33. 4098Long term prognostic value of Cardiac Magnetic Resonance parameters in left ventricular non-compaction
34. P444Effect of sex on reverse remodelling in chronic systolic heart failure
35. 4792Late gadolinium enhancement and arrhythmic risk prediction in patients with LMNA-related cardiomyopathy: results from a long-term follow-up multicenter study
36. P2974Late gadolinium enhancement, reverse remodeling and prognosis in patients with non-ischemic dilated cardiomyopathy and moderate-to-severe systolic dysfunction
37. P5848Different features of cardiac involvement in patients with AL vs. TTR amyloidosis
38. 2059Prognostic relevance of the 40% left ventricular ejection fraction cut-off in chronic systolic heart failure
39. 401Prognostic role of late gadolinium enhancement in patients with low-intermediate 5 year HCM SCD risk score: a multicenter study
40. 186A novel echo-doppler approach for quantitative estimation of pulmonary artery wedge pressure and pulmonary vascular resistances
41. P444Effect of sex on reverse remodelling in chronic systolic heart failure
42. P5848Different features of cardiac involvement in patients with AL vs. TTR amyloidosis
43. 4098Long term prognostic value of Cardiac Magnetic Resonance parameters in left ventricular non-compaction
44. 2059Prognostic relevance of the 40% left ventricular ejection fraction cut-off in chronic systolic heart failure
45. P2974Late gadolinium enhancement, reverse remodeling and prognosis in patients with non-ischemic dilated cardiomyopathy and moderate-to-severe systolic dysfunction
46. P4499Prognostic role of myocardial edema at cardiac magnetic resonance in hypertrophic cardiomyopathy
47. Impact of active smoking on myocardial infarction severity in reperfused ST-segment elevation myocardial infarction patients: the smoker's paradox revisited
48. Cardiac magnetic resonance: late gadolinium enhancement for risk stratification of patients with cardiac amyloidosis
49. Concealed structural abnormalities in patients with apparently idiopathic arrhythmias of left ventricular origin: a magnetic resonance imaging study
50. Cardiac magnetic resonance: evaluation of signal intensity decay after the injection of gadolinium in cardiac amyloidosis
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.